Dialogues in Cardiovascular Medicine - Vol 12 . No. 1 . 2007



HIV & Cardiovascular Disease




N. A. Boon




The cardiovascular manifestations of HIV infection
S. E. Lipshultz, S. D. Fisher, T. L. Miller, T. S. Sharma, A. N. Milton




How does HIV/AIDS cause cardiomyopathy?
W. Lewis


How can excess cardiovascular morbidity be minimized in HIV-infected individuals?
D. J. Betteridge


What can be done about effusive tuberculous pericarditis in HIV-seropositive patients?
A. S. Malin, J. G. Hakim




Matters @ Heart: Isotopes in cardiology
R. J. Bing




S. E. Lipshultz, J. A. Alvarez, J. D. Wilkinson


Immunoglobulins and left ventricular structure and function in pediatric HIV infection
S. E. Lipshultz and others

Cardiac dysfunction and mortality in HIV-infected children: the prospective P2C2 HIV Multicenter study
S. E. Lipshultz and others

Heart muscle disease related to HIV infection: prognostic implications
P. F. Currie and others

Diagnosis, prediction, and natural course of HIV-1 proteaseinhibitor– associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study
A. Carr and others

Cardiovascular status of infants and children of women infected by HIV-1 (P2C2 HIV): a cohort study
S. E. Lipshultz and others
Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV multicenter study
S. D. Fisher and others

Cardiovascular and cerebrovascular events in patients treated for immunodeficiency virus infection
S. A. Bozette and others

Cardiovascular risk and body-fat abnormalities in HIV-infected adults
S. Grinspoon and A. Carr

Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis
S. D. Fisher and others

Class of antiviral drugs and the risk of myocardial infarction
N. Friis-Moller and others




© 2008 LES LABORATOIRES SERVIER, an incorporated company of SERVIER All Rights Reserved - Updates